Newly Named Omicron COVID Variant Causes 400%-Plus Price Pump of Little-Known, Same-Named Crypto
A new potentially deadly COVID strain gets named and an existing cryptocurrency with the same name rockets to life -- talk about an unintended consequence!
- On Friday Nov. 26, the World Health Organization (WHO) identified and named a new COVID-19 variant -- omicron.
- It just so happened that a cryptocurrency has the exact name, and its price soared more than 400% over the weekend.
- Find out how the price action happened and how the WHO picks the names for new pathogens.
On Black Friday, stock markets and cryptocurrencies alike plunged into red after the World Health Organization (WHO) identified and named a new COVID-19 variant -- omicron. The newly discovered and named strain was first detected in South Africa, and during the past 72 hours, additional cases of omicron infections have been found in more than a dozen countries including Australia, Denmark, Netherlands, Israel, and Canada.
There is a lot of worry and concern about whether or not existing COVID vaccines and treatments will have any effect on this latest version of the virus. It's also unclear to global health experts, researchers, and physicians if omicron is more infectious and/or deadly than other mutated iterations.
New disease name already existed for a listed digital asset
Ironically, the price of a relatively-unknown small cryptocurrency -- which also happened to be named Omicron (OMIC) -- soared more than 450% since the WHO named the new COVID-19 strain. As of Friday, the crypto Omicron was trading around $50 per token, but it reached an all-time high of $431.69 as of 9:18 a.m. ET on Sunday per its chart posted at CoinMarketCap.com.
Discover: Best places to buy bitcoin
More: Check out our updated list of best crypto apps including one offer with a $100 crypto bonus
Historic runup for disease-named crypto
Since that parabolic price spike, Omicron has retracted a bit and is down about 16% during the past 24 hours, with a fully diluted market cap of $328 million as of this writing. The OMIC token is described on CoinMarketCap as a "decentralized reserve currency protocol available on the Arbitrum Network...Each OMIC token is backed by a basket of assets (e.g. USDC, OMIC-MIM LP) in the OMIC treasury, giving it an intrinsic value that it cannot fall below. OMIC also introduces unique economic and game-theoretic dynamics into the market through staking and bonding."
How does the WHO pick names of new diseases?
In case you're wondering, the WHO has a specific set of "best practices'' it uses when naming diseases and variants. The global health agency strives to avoid words that invoke fear or link to specific populations, animals, regions, or geographies. Instead the WHO namers prefer terms that focus on the facts and describe clinical symptoms, affected age ranges, severity, seasonality, etc. They also have a specific category that allows the use of "arbitrary identifiers'' such as numbers or the Latin alphabet. This last protocol seems to be what the WHO used to select the omicron name.
How does a 400%-plus price pump occur?
While it's pure speculation as to how the OMIC crypto had a record-setting weekend, one can assume that some trader/investor who knew the OMIC token existed took a page out of the meme token playbook. They decided to take a gamble and jump the market by bidding up the price. They then most likely shared the omicron naming news via a network of similarly-minded investors on some kind of instant message or board. Once they reached critical mass, they pushed the message to go viral. Investors who didn't want to miss out piled on to try and make a pile of cash themselves. We'll see how long Omicron can float on the non-fundamentals' fervor.
Our top crypto play isn't a token - Here’s why
We’ve found one company that’s positioned itself perfectly as a long-term picks-and-shovels solution for the broader crypto market — Bitcoin, Dogecoin, and all the others. In fact, you've probably used this company's technology in the past few days, even if you've never had an account or even heard of the company before. That's how prevalent it's become.
Sign up today for Stock Advisor and get access to our exclusive report where you can get the full scoop on this company and its upside as a long-term investment. Learn more and get started today with a special new member discount.
It's disconcerting to see such arbitrary price action based solely on a name -- especially when you consider it's the name of a potentially more deadly COVID pathogen than we've all been fighting the past 18 months. It appears we may either be becoming desensitized to the viral threat of COVID or willing to exploit nearly anything to make money -- and neither scenario is especially comforting.
Our Research Expert
We're firm believers in the Golden Rule, which is why editorial opinions are ours alone and have not been previously reviewed, approved, or endorsed by included advertisers. The Ascent does not cover all offers on the market. Editorial content from The Ascent is separate from The Motley Fool editorial content and is created by a different analyst team.